Anti-Fibrotic Effect of Losartan, an Angiotensin II Receptor Blocker, Is Mediated through Inhibition of ER Stress via Up-Regulation of SIRT1, Followed by Induction of HO-1 and Thioredoxin.
about
Anti-Fibrotic Effect of Losartan, an Angiotensin II Receptor Blocker, Is Mediated through Inhibition of ER Stress via Up-Regulation of SIRT1, Followed by Induction of HO-1 and Thioredoxin.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Anti-Fibrotic Effect of Losart ...... ction of HO-1 and Thioredoxin.
@en
Anti-Fibrotic Effect of Losart ...... ction of HO-1 and Thioredoxin.
@nl
type
label
Anti-Fibrotic Effect of Losart ...... ction of HO-1 and Thioredoxin.
@en
Anti-Fibrotic Effect of Losart ...... ction of HO-1 and Thioredoxin.
@nl
prefLabel
Anti-Fibrotic Effect of Losart ...... ction of HO-1 and Thioredoxin.
@en
Anti-Fibrotic Effect of Losart ...... ction of HO-1 and Thioredoxin.
@nl
P2093
P2860
P356
P1476
Anti-Fibrotic Effect of Losart ...... ction of HO-1 and Thioredoxin.
@en
P2093
Chung Hee Baek
Hyosang Kim
Jai Won Chang
Raymond Bok Lee
Sang Koo Lee
Won Seok Yang
P2860
P356
10.3390/IJMS18020305
P407
P577
2017-01-31T00:00:00Z